Elliott Investment Management is urging Phillips 66 to sell its stake in Chevron Phillips Chemical, asserting that the conglomerate structure impedes performance. Pemex plans to invest nearly $1 billion to enhance its petrochemical production. BASF is divesting its Brazilian consumer paint division to Sherwin Williams for $1.5 billion. Dongjin Semichem is set to build a $110 million plant in Texas, while Pilot Chemical will expand its α-olefin sulfonate capacity in Ohio. LG Chem plans to produce biobased acrylic acid, and Chemours will exit fluorosurfactants. Notably, Biogen partners with Stoke Therapeutics for a rare epilepsy treatment.